[1]
Bettuzzi, T., Bachelez, H., Beylot-Barry, M., Arlégui, H., Paul, C., Viguier, M., Mahé, E., Beneton, N., Jullien, D., Richard, M.-A., Joly, P., Tubach, F., Dupuy, A., Sbidian, E. and Chosidow, O. 2022. Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort. Acta Dermato-Venereologica. 102, (Mar. 2022), adv00665. DOI:https://doi.org/10.2340/actadv.v101.566.